Cambridge-based Qureight, a clinical data curation and analytics company, has raised £1.5 million seed funding to develop AI-powered platform allowing to collect data from complex diseases.
“Qureight’s platform technology will allow biopharma companies to recruit fewer patients for clinical trials and more precisely target the right kind of patients – saving money and producing better outcomes with a personalised approach to drug development”, said CEO Dr Muhunthan Thillai.
Qureight is currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre at Cambridge Judge Business School.
Read the full article [www.businessweekly.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments